These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24211842)

  • 1. Light chain (κ/λ) ratio of GM-CSF autoantibodies is associated with disease severity in autoimmune pulmonary alveolar proteinosis.
    Nei T; Urano S; Itoh Y; Kitamura N; Hashimoto A; Tanaka T; Motoi N; Kaneko C; Tazawa R; Nakagaki K; Arai T; Inoue Y; Nakata K
    Clin Immunol; 2013 Dec; 149(3):357-64. PubMed ID: 24211842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune pulmonary alveolar proteinosis.
    Uchida K; Nakata K; Carey B; Chalk C; Suzuki T; Sakagami T; Koch DE; Stevens C; Inoue Y; Yamada Y; Trapnell BC
    J Immunol Methods; 2014 Jan; 402(1-2):57-70. PubMed ID: 24275678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM-type GM-CSF autoantibody is etiologically a bystander but associated with IgG-type autoantibody production in autoimmune pulmonary alveolar proteinosis.
    Nei T; Urano S; Motoi N; Takizawa J; Kaneko C; Kanazawa H; Tazawa R; Nakagaki K; Akagawa KS; Akasaka K; Ichiwata T; Azuma A; Nakata K
    Am J Physiol Lung Cell Mol Physiol; 2012 May; 302(9):L959-64. PubMed ID: 22367782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occupational inhalational exposure and serum GM-CSF autoantibody in pulmonary alveolar proteinosis.
    Xiao YL; Xu KF; Li Y; Li Y; Li H; Shi B; Zhou KF; Zhou ZY; Cai HR
    Occup Environ Med; 2015 Jul; 72(7):504-12. PubMed ID: 25995295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memory B cell pool of autoimmune pulmonary alveolar proteinosis patients contains higher frequency of GM-CSF autoreactive B cells than healthy subjects.
    Nei T; Urano S; Motoi N; Hashimoto A; Kitamura N; Tanaka T; Nakagaki K; Takizawa J; Kaneko C; Tazawa R; Nakata K
    Immunol Lett; 2019 Aug; 212():22-29. PubMed ID: 31195018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.
    Bonfield TL; Russell D; Burgess S; Malur A; Kavuru MS; Thomassen MJ
    Am J Respir Cell Mol Biol; 2002 Oct; 27(4):481-6. PubMed ID: 12356582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autoantibody against granulocyte-macrophage colony-stimulating factor and other serum markers in pulmonary alveolar proteinosis].
    Xu KF; Chen Y; Guo ZJ; Zhu YJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):824-8. PubMed ID: 15730782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody.
    Arai T; Kasai T; Shimizu K; Kawahara K; Katayama K; Sugimoto C; Hirose M; Okamoto H; Tachibana K; Akira M; Inoue Y
    Intern Med; 2020 Oct; 59(20):2539-2546. PubMed ID: 32611952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis.
    Ohashi K; Sato A; Takada T; Arai T; Nei T; Kasahara Y; Motoi N; Hojo M; Urano S; Ishii H; Yokoba M; Eda R; Nakayama H; Nasuhara Y; Tsuchihashi Y; Kaneko C; Kanazawa H; Ebina M; Yamaguchi E; Kirchner J; Inoue Y; Nakata K; Tazawa R
    Respir Med; 2012 Feb; 106(2):284-93. PubMed ID: 22112784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis.
    Ohashi K; Sato A; Takada T; Arai T; Kasahara Y; Hojo M; Nei T; Nakayama H; Motoi N; Urano S; Eda R; Yokoba M; Tsuchihashi Y; Nasuhara Y; Ishii H; Ebina M; Yamaguchi E; Inoue Y; Nakata K; Tazawa R
    Eur Respir J; 2012 Mar; 39(3):777-80. PubMed ID: 22379153
    [No Abstract]   [Full Text] [Related]  

  • 11. CYFRA 21-1 as a disease severity marker for autoimmune pulmonary alveolar proteinosis.
    Arai T; Inoue Y; Sugimoto C; Inoue Y; Nakao K; Takeuchi N; Matsumuro A; Hirose M; Nakata K; Hayashi S
    Respirology; 2014 Feb; 19(2):246-252. PubMed ID: 24251830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological and clinical features of idiopathic pulmonary alveolar proteinosis in Japan.
    Inoue Y; Nakata K; Arai T; Tazawa R; Hamano E; Nukiwa T; Kudo K; Keicho N; Hizawa N; Yamaguchi E; Eda R; Oishi K; Maeda Y; Koreeda Y; Kodo N; Sakatani M
    Respirology; 2006 Jan; 11 Suppl():S55-60. PubMed ID: 16423273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic investigation of the detection of granulocyte-macrophage colony stimulating factor antibody in serum for pulmonary alveolar proteinosis].
    Li YQ; Chen YS; Li HR; Shang Y; Gao ZC
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 May; 36(5):351-6. PubMed ID: 24047809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of serum anti-GM-CSF autoantibody levels in autoimmune pulmonary alveolar proteinosis.
    Nishimura M; Yamaguchi E; Takahashi A; Asai N; Katsuda E; Ohta T; Ohtsuka Y; Kosaka K; Matsubara A; Tanaka H; Yokoe N; Kubo A; Konno S; Baba K
    Biomark Med; 2018 Feb; 12(2):151-159. PubMed ID: 29202602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune Pulmonary Alveolar Proteinosis Complicated by Myelodysplastic Syndrome.
    Shimaya M; Inagaki Y; Arai T; Kawakami M; Takeuchi N; Sumikawa H; Shimizu S; Takimoto T; Inoue Y
    Intern Med; 2024 May; 63(10):1451-1457. PubMed ID: 37839886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine profiles associated with disease severity and prognosis of autoimmune pulmonary alveolar proteinosis.
    Akasaka K; Amano M; Nakamura T; Nishizawa T; Yamakawa H; Sato S; Aoki A; Shima K; Matsushima H; Takada T
    Respir Investig; 2024 Jul; 62(4):610-616. PubMed ID: 38705133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis.
    Uchida K; Beck DC; Yamamoto T; Berclaz PY; Abe S; Staudt MK; Carey BC; Filippi MD; Wert SE; Denson LA; Puchalski JT; Hauck DM; Trapnell BC
    N Engl J Med; 2007 Feb; 356(6):567-79. PubMed ID: 17287477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates.
    Sakagami T; Beck D; Uchida K; Suzuki T; Carey BC; Nakata K; Keller G; Wood RE; Wert SE; Ikegami M; Whitsett JA; Luisetti M; Davies S; Krischer JP; Brody A; Ryckman F; Trapnell BC
    Am J Respir Crit Care Med; 2010 Jul; 182(1):49-61. PubMed ID: 20224064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the immunolocalization of surfactant protein (SP)-A, SP-D, and KL-6 in pulmonary alveolar proteinosis.
    Kobayashi M; Takeuchi T; Ohtsuki Y
    Pathol Int; 2008 Mar; 58(3):203-7. PubMed ID: 18251786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplexed particle-based anti-granulocyte macrophage colony stimulating factor assay used as pulmonary diagnostic test.
    Bonfield TL; John N; Barna BP; Kavuru MS; Thomassen MJ; Yen-Lieberman B
    Clin Diagn Lab Immunol; 2005 Jul; 12(7):821-4. PubMed ID: 16002629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.